A Phase Ib Study of PRJ1-3024 for Treatment of Advanced or Metastatic Melanoma

NCT06727630 · clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
RECRUITING
Status
40
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Zhuhai Yufan Biotechnologies Co., Ltd